IAA
IMUX icon

Independent Advisor Alliance’s Immunic IMUX Stock Holding History

Independent Advisor Alliance’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,006
Closed -$804K – 469
2019
Q2 		$804K Buy
+7,006
New +$920K 0.12% 166

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Independent Advisor Alliance's IMUX Position: Q3 2019 in Review

Independent Advisor Alliance sold out of Immunic (IMUX) in Q3 2019, closing a stake of 7,006 shares — an estimated $804K sold.

Independent Advisor Alliance first reported a position in IMUX in Q2 2019 and held it in 1 quarter. The position peaked at $804K in Q2 2019. 24 funds tracked by Wall St. Rank hold IMUX as of Q3 2019.

  • Independent Advisor Alliance reported no remaining Immunic position as of Q3 2019 after selling out during the quarter.
  • Independent Advisor Alliance sold 7,006 Immunic shares in Q3 2019, an estimated $804K.
  • Independent Advisor Alliance first reported a position in Immunic in Q2 2019 and held it in 1 quarter.
  • Independent Advisor Alliance's Immunic position peaked at $804K in Q2 2019.
  • 24 funds tracked by Wall St. Rank held Immunic as of Q3 2019.

Based on Independent Advisor Alliance's 13F filing for Q3 2019, filed 12 Nov 2019.